When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

Neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, pose a significant global health challenge due to their complex pathogenesis and widespread ...

Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

Multiple sclerosis cannot be completely prevented, and certain risk factors — such as age, sex, and family history — cannot be modified. However, changing your diet and lifestyle may help ...

Alemtuzumab, a humanized monoclonal antibody, shows promise as a disease-modifying therapy for multiple sclerosis. This review examines its safety and efficacy, along with current therapies for MS.

Each type is defined by how the disease has progressed throughout the body. Early identification and prompt treatment of MS may help slow or prevent its progression. Multiple sclerosis (MS) is ...